MGF stands for mechano growth factor. It is not a separate hormone but a splice variant of insulin-like growth factor 1 (IGF-1), the form sometimes written IGF-1Ec in humans (IGF-1Eb in rodents). When the IGF-1 gene is read out differently in mechanically loaded or damaged muscle, the resulting transcript carries a 49-base-pair insert in exon 5 that changes the reading frame and produces a distinct C-terminal sequence. The peptide most people mean by "MGF" is the 24-amino-acid E-domain fragment derived from that variant.
The idea traces back to Geoffrey Goldspink and colleagues at University College London in the late 1990s. A 1999 study in the Journal of Physiology reported that rabbit skeletal muscle subjected to stretch plus electrical stimulation switched on this IGF-1 isoform, separate from the liver-type IGF-1Ea. That gave rise to the name and to a hypothesis: muscle makes its own local, load-responsive IGF-1 signal rather than depending only on circulating growth hormone and liver IGF-1.
What it is proposed to do
The attractive part of the MGF story is a division of labour. In cell-culture and animal work, the MGF E-peptide on its own appears to activate quiescent satellite cells (muscle stem cells) and push myoblast proliferation, while mature IGF-1 drives the later differentiation step. Synthetic MGF peptide has shown effects beyond muscle too. In a PubMed-indexed study in SOD1(G93A) mice, an MGF/IGF-1 splice variant rescued motoneurons and improved muscle function, and other work reported increased progenitor cell numbers in dystrophic, ALS-model and normal muscle.
Where the evidence is shaky
Here the honest caveats matter. A 2010 minireview in Endocrinology by Matheny, Nindl and Adamo pushed back hard on the core claim. Their review concluded there is "inadequate evidence" that a free 24-amino-acid MGF peptide is actually a product of IGF-1 gene expression in living tissue. No one has isolated that endogenous peptide from tissue or fluid, and no clear enzymatic route to cleave it from pro-IGF-1 has been established. Antibody signals attributed to MGF often pick up larger proteins instead.
The practical reading: the mRNA splice variant is real and does rise during muscle repair. The synthetic peptide does have measurable activity in dishes and in rodents. Whether a naturally occurring free MGF peptide exists and acts as the hypothesis claims is still disputed, and effects of injected synthetic peptide cannot simply be read back onto endogenous biology.
Human clinical trials specifically testing MGF are essentially absent. Almost everything documented is preclinical or animal work.
Half-life, PEG-MGF, and the products sold online
Native MGF is metabolised within minutes, which is part of why it never became a practical therapeutic. The vials marketed online are usually stabilised synthetic analogs, including a PEGylated version ("PEG-MGF") engineered to slow degradation, and sometimes versions using unnatural D-amino acids in the central QRRK region. These are not the natural molecule and are not equivalent to anything tested in the published animal literature.
Regulatory and WADA status
MGF is not an approved drug anywhere. It is sold as a research chemical, for laboratory research use only, not for human consumption. It has been on the World Anti-Doping Agency Prohibited List since 2005 and sits under class S2 (peptide hormones, growth factors and related substances). Detection methods for doping control exist. Some jurisdictions, including Australia and Canada, treat IGF variants as prescription-only.
The quality angle for buyers
Because no regulator oversees these products, there is no guarantee that a vial labelled MGF or PEG-MGF contains the stated peptide, at the stated amount, at any particular purity. Independent third-party testing is the only check a buyer has. A meaningful certificate of analysis identifies the actual lab, ties to a specific lot, and reports identity (typically mass spectrometry) and purity (typically HPLC). peptideone aggregates third-party COAs and vendor ratings so these can be compared rather than taken on trust. None of this is medical, dosing or efficacy advice.